Pradelli, L., & Ascierto, P. (2016). [Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market]. Farmeconomia. Health Economics and Therapeutic Pathways, 17(3S), 1–32. https://doi.org/10.7175/fe.v17i3S.1279